To use this feature, join Babbler easily !
Nice to see you again !
minutes reading time
minute reading time
CURRENTLY IN REGULATORY REVIEW IN THE EU AND U.S. FOR USE AS AN ADJUNCT TO INSULIN THERAPY TO IMPROVE GLYCEMIC CONTROL IN ADULTS WITH TYPE 1 DIABETES
Sotagliflozin is the first investigational, oral SGLT-1/2 dual inhibitor in clinical development for Type 1 Diabetes (T1D)
- Health & Medicine
- Men's Health
- Women's Health